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ABSTRACT:  The imine reductase AoIRED from Amycolatopsis orientalis (Uniprot R4SNK4) 
catalyzes the NADPH-dependent reduction of a wide range of prochiral imines and iminium 
ions, predominantly with (S)-selectivity and with e.e.s of up to >99%.  AoIRED displays up to 
100-fold greater catalytic efficiency for 2-methyl-1-pyrroline (2MPN) compared to other IREDs, 
such as the enzyme from Streptomyces sp. GF3546, which also exhibits (S)-selectivity, and thus 
AoIRED is an interesting candidate for preparative synthesis.  AoIRED exhibits unusual catalytic 
properties, with inversion of stereoselectivity observed between structurally similar substrates, 
and also, in the case of 1-methyl-3,4-dihydroisoquinoline, for the same substrate, dependent on 
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the age of the enzyme after purification.  The structure of AoIRED has been determined in an 
‘open’ apo-form, revealing a canonical dimeric IRED fold in which the active site is formed 
between the N- and C-terminal domains of participating monomers.   Co-crystallisation with 
NADPH gave a ‘closed’ form in complex with the cofactor, in which a relative closure of 
domains, and associated loop movements, has resulted in a much smaller active site.  A ternary 
complex was also obtained by co-crystallization with NADPH and 1-methyl-1,2,3,4-
tetrahydroisoquinoline [(MTQ], and reveals a binding site for the (R)-amine product which 
places the chiral carbon within 4 Å of the putative location of the C4 atom of NADPH that 
delivers hydride to the C=N bond of the substrate.  The ternary complex has permitted structure-
informed mutation of the active site, resulting in mutants including Y179A, Y179F and N241A, 
of altered activity and stereoselectivity.  
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INTRODUCTION 
The asymmetric synthesis of chiral amines is of central importance to the chemical industries, 
as these moieties feature in a large proportion of pharmaceuticals and agrochemicals.  Recently a 
number of approaches have been reported for the biocatalytic synthesis of chiral amines,
1
 
including the application of hydrolases,
2
 transaminases,
3
 amine oxidases
4
 and amine 
dehydrogenases.
5-7
 The direct reduction of prochiral imines by NAD(P)H-dependent 
oxidoreductases, termed imine reductases or IREDs, is now receiving more attention, after 
studies by Mitsukura and Nagasawa
8-10
 demonstrated that two strains of Streptomyces contained 
NADPH-dependent oxidoreductases capable of stereocomplementary reductions of the model 
substrate 2-methyl pyrroline (2-MPN, 1a, Scheme 1).   
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Since the initial identification of these (R)- and (S)-selective IREDs, several groups have now 
reported the isolation and application of further oxidoreductases from a wider subfamily that are 
capable of the asymmetric reduction of prochiral imine substrates with a high degree of 
stereoselectivity.
11-17
  The latest developments in this area has been summarized in three recent 
reviews.
18-20
  The interest in IREDs has been stimulated by the possibility that the enzymes may 
offer advantages of selectivity and environmentally benign methodology compared to abiotic 
methods of asymmetric imine reduction that employ transition metal catalysts.
21 
 
 
Scheme 1. Stereocomplementary reductions of 2-MPN 1a by Streptomyces spp. 
The mechanism of IREDs is not well understood and indeed it appears that different members 
of the family employ different amino acid residues within the active site for substrate recognition 
and/or catalysis.  The first structure of an enzyme for which NADPH-dependent IRED activity 
towards 1a had been demonstrated was the enzyme Q1EQE0 from Streptomyces kanamyceticus, 
which catalyzes the (R)-selective reduction of 1a albeit with low activity.
16
  The structure of this 
IRED consists of an intimate homodimer in which the two active sites are located at the interface 
between an N-terminal Rossman domain of one subunit, and a C-terminal helical bundle in the 
other.  The domains in each monomer are connected by a long helix from which an aspartate 
residue, Asp187, protrudes into the active site, with its side chain approximately 8 Å from the C4 
atom of the nicotinamide ring of NADPH that delivers and accepts hydride.  The structure is 
most similar to an hydroxyisobutyrate dehydrogenase 2CVZ,
22
 in which a lysine residue, which 
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superimposed with the aspartate in Q1EQE0, was suggested to be the proton donor to the nascent 
alcohol in the reduction of the titular substrate by that enzyme.  By analogy, it was proposed that 
Asp187 may act as a proton donor in the reduction of imine substrates, and indeed mutation of 
this residue to Ala or Asn by ourselves
16
 and other groups
13
 in Q1EQE0 and homologs, resulted 
in variants with reduced catalytic activity.  Interestingly, in IREDs that possess (S)-selectivity 
towards 1a, the Asp/Lys position is occupied by a tyrosine residue, which in this case has its 
phenolic hydroxyl group positioned approximately 5 Å from the NADPH C4 atom, possibly as a 
proton donor, as has been demonstrated for the IRED pteridine reductase previously.
23
  The 
location of this tyrosine was revealed using structures of (S)-selective IREDs from 
Streptomyces,
12
 Bacillus
24
 and Nocardiopsis
24 
and its mutation to Ala
13
 or Phe
24
 has again been 
shown to diminish IRED activity in such enzymes. 
Recent work by Pleiss and Hauer
13
 has shown that there exists a much wider family of 
potential IREDs, with a range of different amino acids in the Lys/Asp/Tyr position as predicted 
by sequence alignments.  Indeed Wetzl and co-workers
17
 have recently shown that some of these 
homologs contain residues with aprotic side-chains, such as phenylalanine, in this position.  
Despite the mutational investigations at this position, the absolute requirement for a proton donor 
in IRED catalysis has not been clarified, as it may be that the imine substrate is already 
protonated in solution prior to hydride delivery. We were prompted therefore to pursue structural 
and mechanistic investigations of an IRED with an aprotic residue in the Lys/Asp/Tyr position, 
and we selected the IRED homolog Uniprot code R4SNK4 (named AoIRED) from the 
vancomycin producer Amycolatopsis orientalis, which features an Asn residue in this position.  
Biotransformation and kinetics studies reveal AoIRED to be predominantly (S)-selective, with 
superior activity to previously described (S)-IREDs, and also to possess surprising properties that 
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include inversions of stereoselectivity upon very small changes in substrate structure, and also, 
with four of the substrates, upon storage of the enzyme.  In addition, structural investigations 
have yielded both an apo-structure and an NADPH complex, but also a ternary complex with a 
reaction product, (R)-1-methyl-1,2,3,4-tetrahydroisoquinoline [(R)-MTQ].  The structures have 
informed rational mutagenesis studies of AoIRED, but also suggest a significant role for protein 
dynamics in catalysis by this enzyme. 
 
RESULTS 
Substrate specificity and stereoselectivity 
The gene encoding AoIRED was cloned and expressed in E. coli, and the protein purified using 
protocols detailed in the Supporting Information (Section S2).  Following purification, the effects 
of pH and temperature on the activity of AoIRED using 1a as substrate were determined 
(Supporting Information; Section S3).  The pH optimum was found to be 7.5 and the temperature 
optimum 50°C, although rapid denaturation was also observed at this temperature. In order to 
characterize the activity of AoIRED with respect to substrate scope we examined a broad range 
of cyclic imines. When stored at 4°C at a concentration of 2 mg mL
-1
, the enzyme retained >90% 
activity after 4 weeks.   Examination of a series of 2-substituted pyrrolines (1a-d), piperideines 
(3a-g) and azepines (5a-b)  (Scheme 2, Table 1) established that AoIRED catalyzes reduction of 
the 2-methyl-substituted derivatives (1a, 3a & 5a) predominantly to the corresponding (S)-amine 
products with excellent e.e.s of up to 98%.  
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Scheme 2. Monocyclic prochiral imines reduced by fresh purified AoIRED.  
Table 1. Monocyclic prochiral imines reduced by fresh purified AoIRED.  
 
Substrate Product Conversion 
(%) 
e.e. 
(%) 
Absolute 
Configuration 
1a 2a 96 n.d.
[c] 
(S)- 
1b 2b 100 95 (S)- 
1c 2c 98 >99 (S)- 
1d 2d 85 >99 (R)- 
3a 4a >99 98
 
(S)- 
3b 4b >99 40 (S)- 
3c 4c >99 60 (R)- 
3d 4d 77 90 (R)- 
3e 4e >99 71 (S)- 
3f 4f >99 4 (R)- 
3g 3g >99 >99 (R)- 
5a 6a 95 >99 (S)-
[a]
 
5b 6b 76 96 (-)
[b]
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[a]
Inversion of selectivity was observed when a 24 h old aliquot of AoIRED was used as the 
catalyst. Results of biotransformations using fresh purified AoIRED are presented. 
[b]
 Absolute 
configuration not determined.
[c]
 Lack of baseline separation prevented e.e. calculation; see 
Figure S7.  
Interestingly, and in contrast to the selectivity pattern observed with the Streptomyces 
IREDs
10,15
 the (S)-amine products were also preferentially formed upon reduction of 2-
phenylpyrroline 1b (95% e.e.) and 2-phenylpiperideine 3b (40% e.e.), which, due to a change in 
Cahn-Ingold-Prelog priority, represents an actual inversion of stereoselectivity, in which hydride 
attacks the opposite face of the substrate. Remarkably, replacement of phenyl by a para-
fluorophenyl 3c or para-methoxyphenyl 3d substituent on the piperideine ring led to a reversal 
of stereoselectivity, yielding (R)-4c (60% e.e.) and (R)-4d (90% e.e.) respectively. These results 
suggest that very small changes in the substrate, in this case replacement of H by F or OMe, can 
lead to dramatic changes in the stereoselectivity of reduction, presumably through associated 
changes in the substrate binding mode.  Interestingly, transformation of azepine 5a using fresh 
purified AoIRED gave the (S)-amine, as shown in Table 1, but using older enzyme, the 
stereoselectivity was shown to invert, yielding the (R)-product.  This phenomenon is described in 
more detail below. 
Inversion of stereoselectivity in the reduction of 1-methyl-3,4-dihydroisoquinoline 9. 
Further evidence of selectivity changes upon binding were observed when using 
dihydroisoquinoline and -carboline substrates (Scheme 3, Table 2).  
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Scheme 3. Bulky prochiral imines reduced by fresh purified AoIRED. 
Table 2.  Bulky prochiral imines reduced by fresh purified AoIRED.  
 
[a] Inversion of selectivity  was observed when a 24 h old aliquot of AoIRED was used as the 
catalyst. Results of biotransformations using fresh purified AoIRED are presented. n/a= not 
applicable. 
Thus reduction of -carboline 13a yielded the (R)-product (99% e.e.), albeit in low yield, 
whereas reduction of 13c, which features a methoxy substituent on the phenyl ring, yielded the 
(S)-amine (79% e.e.).  Even more remarkable was the reduction of 1-methyl-3,4-
Substrate Product Conversion 
(%) 
e.e. (%) Absolute configuration 
7 8 100 n/a n/a 
9 10 100 81 (S)-
[a]
 
11 12 50 79 (S)- 
13a 14a 5 >99 (R)- 
13b 14b 66 71 (R)- 
13c 14c 15 79 (S)-
[a]
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dihydroisoquinoline 9, in which the stereoselectivity of reduction was found to depend upon the 
form and age of the biocatalyst used. Thus a fresh lysate of cells expressing AoIRED converted 9 
to (S)-10 (85% e.e.) as did fresh purified enzyme (81% e.e.). However, an aliquot of purified 
AoIRED stored at 4°C for 24 h converted 9 to (R)-10 (98% e.e.) (Figure 1).  Monitoring the 
stereoselectivity as a function of storage time showed a steady increase in the preponderance of 
(R)-10, eventually leading to total inversion of enantioselectivity towards 9 with an excellent e.e. 
of 95-98% within 24 h and >99% after 14 d. Varying the reaction pH from 6-10 did not have any 
effect on the selectivity change. Any contribution to the effect from the recycling enzyme 
glucose dehydrogenase (GDH) was ruled out, as the inversion of stereochemistry was  
 
Figure 1.  Selectivity switch of AoIRED towards 1-methyl-3,4-dihydroisoquinoline 9. AoIRED 
in whole cell, fresh lysate and fresh purified form yielded (S)-10, whereas older stocks of the 
protein yielded (R)-10. (Experiments were repeated with three different batches of AoIRED and 
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standard deviations are represented with error bars; On the y-axis, ‘-100 % e.e. indicates 100% 
e.e. for the (S)-enantiomer; ‘100 % e.e.’ indicates 100% e.e. for the (R)-. 
also observed when the reactions were performed with stoichiometric NADPH. The addition or 
removal of imidazole, which was employed in purification, and may have interfered with 
substrate binding, from the enzyme preparations, also did not have any effect, nor did the 
addition of 1-20 mM DTT, added in an effort to slow the oxidation of active site thiols.  
Attempts to reverse the selectivity of the older enzyme towards 9 were unsuccessful.  An 
inversion of stereoselectivity in the KRED from T. ethanolicus, reported by Phillips and co-
workers,
25
 prompted us to study the stereoselectivity of reduction of 9 at different temperatures 
by 7 day old enzyme, but no effect was observed. To investigate any peptide-assisted behavior of 
AoIRED, we incubated the purified old stock of AoIRED with crude extract from E. coli bearing 
an empty pET-28a vector, using the same conditions for cultivation and induction as used in the 
AoIRED whole-cell system, but again, no effect was observed. However, the addition of equal 
concentrations of bovine serum albumin (BSA) to the freshly purified AoIRED was shown to 
slow the transformation from an (S)- to (R)-selective enzyme. A 24 h old aliquot of purified 
AoIRED containing BSA (5-10 times the concentration of AoIRED), added immediately after 
purification, afforded (S)-10 with 76% e.e., whereas a 24 h old ‘AoIRED-only’ aliquot yielded 
(R)-10 (98% e.e.). Eventually, a 72 h old aliquot of ‘AoIRED + BSA’ challenged with 9 yielded 
(R)-10 (e.e 98%).  
 
Stereoselective reduction of iminium ions 
Tertiary chiral amines are important structural motifs in pharmaceuticals, and could in theory 
be obtained through the IRED-mediated reduction of iminium ions.  Indeed, recent reports by 
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Zheng, Xu and co-workers have demonstrated that (R)- and (S)-selective IREDs from 
Paenibacillus lactis catalyzed the reduction of indoline iminium ions with excellent 
stereoselectivity.
26, 27
 The ability of AoIRED to catalyze the reduction of iminium ions was tested 
using substrates 15a-15d, 17, 19a and 19b (Scheme 4, Table 3). Conversions ranged from 6% 
for 15c to 90% for 19a, with good to excellent e.e.s, the best being achieved for substrates 15b 
and 17. The highest conversion obtained was for N-benzylated substrate 15b and N-
methyldihydroisoquinoline 19a, with 79% and 90% respectively.  
Scheme 4. Prochiral iminium ions reduced by fresh AoIRED lysate. 
Table 3. Prochiral iminium ions reduced by fresh AoIRED lysate. 
Substrate Product Conversion 
(%) 
e.e (%) 
 
Absolute 
configuration 
15a 16a 8 66 (R)- 
15b 16b 79 n.d.
[b] 
(R)- 
15c 16c 6 n.d.
[c] 
(R)- 
15d 16d 30 67 (R)- 
17 18 12 90 (R)- 
19a 20a 90 n/a n/a 
19b 20b 40 92 (S)- 
[a]
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[a]  Inversion of selectivity  was observed when a 24 h old aliquot of AoIRED was used as the 
catalyst. Results of biotransformations using fresh AoIRED lysate are presented.
[b]
 Lack of 
baseline separation prevented e.e. calculation; see Figure S19.
 [c]
 Lack of baseline separation 
prevented e.e. calculation; see Figure S20. 
Kinetics 
The determination of the kinetic parameters for representative substrates (Table 4) revealed an 
increasing turnover number with increasing ring size from five- (1a) to six membered (3a) rings 
(1a, 3a). The kcat/Km values for 1a and 3a were 0.17 s
−1
 mM
-1
 and 0.53 s
−1
 mM
-1
 respectively, 
which for 1a is approximately 100-fold greater than the IRED from Streptomyces GF3546 
(kcat/Km  = 0.002 s
−1
 mM
-1
),
11
 which also possesses (S)-selectivity towards 1a, revealing AoIRED 
to be the most catalytically efficient (S)-selective IRED described in this class to date. The 
highest turnover number, and indeed the highest catalytic efficiency, for AoIRED was observed 
with the bicyclic dihydroisoquinoline 7 (kcat = 0.94 s
−1
; kcat/Km = 2.58 s
−1
 mM
-1
) although the 
superior binding affinity for a ligand was observed with the bulky 2-phenylpiperideine 3b (Km = 
0.22 mM).  
 
 
 
 
 
 
 
 
 13 
Table 4.  Steady-state kinetic parameters for selected AoIRED substrates. 
Substrate Km (mM) kcat (s
−1
) kcat/Km (s
−1 mM−1) 
1a 0.87 ± 0.43 0.15 ± 0.08 0.17 ± 0.18 
3a 0.65 ± 0.11 0.35 ± 0.01 0.53 ± 0.11 
3b 0.22 ± 0.01 0.12 ± 0.00 0.38 ± 0.08 
3c 0.51 ± 0.16 0.14 ± 0.01 0.27 ± 0.07 
7 0.36 ± 0.04 0.94 ± 0.01 2.58 ± 0.30 
9 0.72 ± 0.05 0.74 ± 0.02 1.03 ± 0.40 
19b 0.96 ± 0.11 0.77 ± 0.02 0.80 ± 0.20 
 
 
Structural studies of AoIRED 
The structure of AoIRED has been obtained in three forms: an ‘open’ apo-structure, a ‘closed’ 
NADPH complex, and a ternary complex of the ‘closed’ form that also features (R)-10, the 
product of (R)-selective reduction of 2-methyl-dihydroisoquinoline 9.  AoIRED shares the 
intimately associated domain sharing dimeric structure of other IRED structures in the database 
(Figure 2).  
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Figure 2. Dimer structure of AoIRED illustrating the canonical IRED fold with domain sharing 
between subunits.  Structure is shown in ribbon format with monomers A and B in light blue and 
gold.  NADPH is shown in cylinder format with carbon atoms in grey, is shown at the dimer 
interface. 
 Indeed, analysis on the DALI server
28
 indicated that the closest structural homolog was the 
(R)-selective Q1EQE0
16
 (3ZHB; 46% amino acid sequence identity; rmsd 2.3 Å over 282 C-
alpha atoms).  The monomer structure adopts the canonical IRED fold now established for both 
(R)- and (S)-selective enzymes with a standard Rossman fold consisting of residues Thr2 to Gly 
165; the transdomain helix (8) from Leu166 to Ser194 and the C-terminal helical bundle 
formed from 8 and 12, culminating in Arg290.  A full representation of the secondary 
structural motifs can be found in Figure S23.  Superimposition of AoIRED with (R)-selective 
IRED Q1EQE0 and (S)-selective BcSIRED revealed a very high level of conservation of 
structure within the Rossman fold, and indeed within the C-terminal helical bundle.  
Superimposition of the apo-AoIRED with the AoIRED-NADPH complex revealed that the loop 
 15 
Thr225 to Gly236 between helices 9 and 10 displayed a remarkable 180° flip to bring the loop 
from beneath the C-terminal domain to occupy a position towards at the distal region of the 
active site cleft (Figure S24), giving a ‘closed’ form of the active site that is clearly reduced in 
volume compared to the actives site cleft in the apo structure.   The loop movement in the 
NADPH complex appears to result from a 180° flip of the peptide bond between Ala 223 and 
Pro224.  There are also substantial changes in the Rossman fold coincident with NADPH 
binding: the region between Leu69 and Ala78 between strand 4 and helix 4 folds over the 
Rossman domain with the result that the side chain of Tyr72 flips from the NADPH phosphate 
binding pocket on the enzyme periphery in the apo-structure, to the interior of the domain, where 
the phenolic hydroxyl now forms hydrogen bonds with the side chains of Asp118, Tyr116 and 
Ser96 (Figure S25). This moves the C and hydroxyl group of Tyr72 distances of 6 Å and 17 Å 
respectively.  The effect is to remove the side chain of Tyr72 from the ADP binding pocket 
where it would occlude the binding of the adenine ring.  Coincident with this large movement is 
the reorientation of the side chain of Arg36 in the apo-structure from the enzyme periphery to the 
ADP binding pocket, where it now interacts with the ADP ribose 2’ phosphate.  We have termed 
the structure of the apo- and NADPH-complex structures to be the ‘open’ and ‘closed’ forms of 
AoIRED respectively.  
Numerous approaches were taken to obtaining complexes of AoIRED with imine substrate or 
amine products, including a range of ligands in combination with NADPH and NADP
+
.  Co-
crystallization of AoIRED with NADPH and rac-10 yielded a ternary complex that superimposed 
well with the NADPH complex, with an rmsd for the subunit ‘A’ of 0.29 Å over 276 C-alpha 
atoms.  The omit map at the subunit interface revealed density consistent with the presence of the 
(R)-enantiomer of MTQ, (Figure 3), and also for NADPH, excepting the nicotinamide riboside.  
 16 
The binding of NADPH has been sufficient to close the complex around the amine ligand and 
this is now found parallel to the active site cleft, ideally positioned for hydride delivery from 
NADPH to the electrophilic carbon.  The plane of the ligand is stacked against hydrophobic 
residues (A)Leu175 and (A)Met178 on one side of the active site, and (A)Pro124 on the other, 
with the nitrogen atom of (R)-MTQ at 3.4 Å from the amide of Asn241 and 4.4 Å from the 
phenol group of Tyr179.   The side chain of Asn171, homologous with the Asp and Tyr residues 
of (R)- and (S)-selective enzymes studied previously, is relatively remote from the amine-
NADPH interaction, above the aromatic ring of (R)-MTQ as presented in Figure 3 at a distance 
of approximately 5.0 Å.  Superimposition with the NADPH complex revealed that the chiral 
carbon of the ligand would be ideally placed at approximately 3.5 Å from the C4 atom of the 
nicotinamide ring of NADPH that delivers hydride to the electrophilic carbon of the C=N bond.  
The identification of a possible ligand-binding site in the ternary (R)-MTQ complex prompted us 
to mutate local residues in order to gauge their influence on catalytic activity. 
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Figure 3. Detail of amine binding site in ‘closed’ AoIRED (R)-MTQ ternary complex obtained 
through co-crystallization of AoIRED with racemic MTQ and NADPH. The peptide backbone 
and side chain carbon atoms of monomers A and B are colored light blue and gold respectively.  
Electron density corresponds to the Fo – Fc (omit) map contoured at a level of 2.5 (R)-MTQ 
atoms have been added for clarity.  The omit map also features density for the ADP-ribose-2’-
phosphate, but not the nicotinamide riboside, which could not be modelled.  Atoms for the latter 
have been included for illustrative purposes using superimposition with the NADP(H) complex 
structure as a basis. 
Site-directed mutagenesis of AoIRED 
In order to probe the role of various active-site residues within AoIRED a series of site-
directed mutagenesis experiments was performed.  The structure of AoIRED in complex with 
(R)-10 suggested that some residues, such as Tyr179 and Asn241 within or near the 
hydrophophobic pocket opposite the NADPH-binding site may be involved in ligand 
recognition, especially through interactions with the nitrogen atom. These interactions were 
explored through the creation and assay of mutants Y179A, Y179F and N241A.  The 
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contribution to activity of residue Asn171, the pendant residue at the top of the active site as 
pictured in Figure 3, and which corresponds to Asp187 in SkIRED was also assessed through 
assay of mutants N171A and N171D.       
Y179A and Y179F were shown to be active against a broad panel of substrates, showing high 
enantioselectivity in some cases, although the activity of the Y179A mutant was markedly lower 
towards substrates 1a, 1b,  3b and 3d (selected data are presented in Table 5; for full details see 
Table S5). Stereoselectivity towards smaller substrates such as 1a was not affected, but, notably, 
enantioselectivity toward 2-phenylpiperideine 3b and bicyclic imine 11 was inverted for both  
Y179A and Y179F variants. The N241A mutant displayed reduced conversions to the WT for 
smaller substrates, but broader substrate tolerance (Table 5; Table S6). Of particular note were 
the reactions with substrates 11 and 13c, all of which gave higher conversions than the WT 
enzyme, and with inverted stereoselectivity. In general, the N171A and N171D variants gave 
lower conversions than the WT enzyme, reflecting lower activity, and largely with no change in 
stereopreference. (Table 5; Table S7).  
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Table 5.  Biotransformation of selected substrates by active site mutants of AoIRED. 
                  
    Imine 
Data for AoIRED variants [C (%); e.e. (%) and abs. config. amine product] 
WT Y179A Y179F N241A N171A N171D 
1a 96; 82 (S)- 23; 99; (S)- 35; 47 (S)- 43; 81 (S)- 31; >99 
(S)- 
2; >99 (S)- 
1b 100; 95 
(S)- 
8; 99 (S)- 99; 92 (S)- 43; 81 (S)- 100; 4, (S)- 100; 95 
(S)- 
3b 99; 40 (S)- 32; 43 (R)- 93; 8 (R)- 99; 0 41; 68 (S)- 80; 80 (S)- 
3d 70; 90 (R)- 3; 59 (R)- 25; 84 (R)- 56; 72 (R)- 2; 99 (R)- 11; 80 (R)- 
11 50; 79 (S)- 15; >99 
(R)- 
5; 99 (R)- 99; 85 (R)- 2; 31 (S)- 2; 99 (S)- 
13c 15; 62 (S)- 10; 99 (S)- 9; 99 (S)- 96; 60 (R)- 18; 71 (S)- 6; 99 (S)- 
 
 
Kinetic studies of variants of Y179, N241 and N171 using substrates 1a, 7 and 9 (selected data 
are presented in Table 6; further data in Table S8-S10) showed that the Y179A variant displayed 
up to 1.6 fold improved catalytic efficiency towards dihydroisoquinolines 7 and 9, compared to 
the WT, although the Y179F variant was less efficient (Table 6).  N241A displayed comparable 
kinetics overall to the WT, with slight increases in Km.  Analysis of N171A and N171D variants 
revealed that mutations at N171 result in higher Km values and lower turnovers for bicyclic 
substrates (Table 6; Table S10), contributing to lower second-order rate constants overall, 
particularly for the alanine mutant. 
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Table 6.  Kinetic parameters of active site mutants of AoIRED against selected substrates 
                  
    
Imine 
 Kinetic data for AoIRED variants [Km (mM); kcat (s
−1
); kcat/Km 
(s
−1 mM−1)]a 
WT Y179A Y179F N241A N171A N171D 
1a 0.87; 0.15; 
0.17 
1.77; 0.03; 
0.05 
0.87; 0.01; 
0.02 
1.27; 0.22; 
0.17 
7.90; 0.12; 
0.02 
2.22; 0.17; 
0.01 
7 0.36; 0.94; 
2.58 
0.39; 1.52; 
3.95 
0.85; 0.32; 
0.38 
0.47; 0.95; 
2.02 
1.90; 0.15; 
0.08 
1.44; 0.15; 
0.10 
9 0.72; 0.74; 
1.03 
0.45; 0.92; 
2.03 
0.19; 0.07; 
0.36 
0.83; 0.76; 
0.92 
3.15; 0.01; 
0.01 
0.72; 0.21; 
0.30 
 
[a]  Errors have been omitted from this Table for reasons of space, but can be found in relevant 
Tables in the SI. 
DISCUSSION 
AoIRED is an active imine reductase with a broad substrate spectrum and the potential to serve 
as a valuable asymmetric catalyst with certain substrates, including 5- (1b-1d), 6- (3a, 3d) and 7-
(5a) membered moncyclic imines, as well as isoquinolines such as 9 and some iminium ion 
substrates.   However, the situation is complicated by the observation with AoIRED, but also 
other IREDs,
17,24
 of small changes in substrate structure having major changes on stereochemical 
preference.  AoIRED appears to display a mixed stereopreference for substrates that is difficult to 
visualize, as CIP priority changes render the use of ‘re-/si-‘ and ‘R/S’ terminology confusing.  
Scheme 5 shows that one set of substrates, exemplified by 1a, 2a and 3d are attacked by hydride 
at the prochiral face of the molecule with the imine bond on the right-hand side of the nitrogen 
atom; conversely, the second set of substrates, represented by 3b, 3c and 9 (by stored AoIRED) 
are attacked on the prochiral face with the imine bond on the left-hand side of the nitrogen atom. 
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Scheme 5.  Two sets of prochiral imines representative of alternate stereochemical outcomes in 
reductions by AoIRED.  The NADPH hydride attacks compounds grouped A or B from the front 
of the page in each case. 
 Even the very small changes in structure between 3d and 3b require that AoIRED must invert 
the substrate to present the opposite face to the nicotinamide ring for the attack of hydride at the 
electrophilic carbon of the C=N bond.  This may implicate the use of more than one binding 
mode, or even binding site, for different substrates.  A multiplicity of binding modes is also one 
possible explanation suggested by the remarkable inversion of stereoselectivity observed for the 
reduction of substrate 9 on storage of the enzyme, and the plasticity of the active site suggested 
by structural studies may also play a role in the complex behavior observed. 
An extreme example of the unusual stereoselective properties of AoIRED is the inversion of 
stereopreference in the reduction of 1-methyl-3,4-dihydroisoquinoline 9.  Both fresh lysate and 
fresh purified AoIRED catalyzed the formation of the (S)-amine product 10, but storage yielded 
an enzyme that catalyzed the formation of the (R)- enantiomer.  Despite many investigations, it 
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did not prove possible to reverse this effect, although BSA was shown to slow the transformation 
from an (S)- to an (R)- selective enzyme.  BSA is known to stabilize the conformation of proteins 
including dehydrogenases through hydrophobic effects
29
 and also to alter kinetic and 
thermodynamic parameters through molecular crowding,
30
 although we are unaware of any 
associated effects on the stereoselectivity of enzymes.  Possible explanations for the observed 
inversions of stereoselectivity could therefore include conformational changes or changes in 
protein oligomerization on storage, but also possibly changes in the hydration of the active site 
cleft, which have been observed by Phillips to invert the enantioselectivity of the KRED from T. 
ethanolicus.
31
 Given the time scale of the conformational change, X-ray crystallographic studies 
have not been able to shed light on the phenomenon of inverted stereoselectivity, but do provide 
information on some of the mobile elements in AoIRED.    
The structures of AoIRED suggest that multiple conformations of the enzyme are indeed to be 
encountered along the reaction coordinate, with major loop reorganisations observed on cofactor 
binding.  Some of this mobility, such as the movement of the tyrosine loop in the N-terminal 
domain, may be general, as this tyrosine is observed in all currently known IRED structures.  
The loop movements beneath the active site in AoIRED, however, may be restricted to closely 
related homologs, as there is clearly some diversity in IRED sequences in this region.  This loop 
movement, in conjunction with the relative closure of the two domains that participate in active 
site formation, serves to close the active site to form a pocket that is much reduced in volume 
compared to the active site cleft that has been observed in IRED structures previously, and in 
which cofactor and substrate can interact for the reduction reaction. One abiding mystery of 
IRED catalysis is the ability of stereocomplementary enzymes to catalyze the production of 
antipodal amine products using apparently large active site clefts that appear to be fairly similar 
 23 
in nature.  The observation of the smaller closed active site in the AoIRED ternary complex 
suggests a ligand recognition site, at least in this enzyme, that is now small enough to possibly 
exert control over which prochiral face of the imine is presented to the hydride. 
In the time taken to acquire pure AoIRED and to crystallize it, it is probable that the form of 
the enzyme in crystallization drops is the (R)-selective form, and, indeed it is the (R)- enantiomer 
of 10 that is found in the ternary complex structure obtained by co-crystallizing AoIRED with 
NADPH and racemic 10.  This complex placed cofactor, amine and active site in context, and 
allowed a structure-guided approach to the possible roles of residues through mutational 
analysis.  Although N241 especially appears to interact directly with the nitrogen atom of the 
amine product, it cannot act as a general acid in protonation of the reaction intermediate.  Indeed 
the imine substrate is probably protonated at the pH values used for bioconversions, so such 
protonation may not be necessary. However, it may act as an anchor for the nitrogen atom that 
fixes the ligand for reduction at the si- face of the substrate in this case.  Mutation of N241 to 
alanine resulted in slight increases in the Km for 1, 7 and 9, and also created a more efficient 
enzyme for the transformation of large substrates such as 11 and 13c, although its effect on 
enantioselectivity was mixed, dependent on the substrate.  In the same region, mutation of Y179, 
which makes more distant contact with the amine nitrogen, to alanine actually created a more 
efficient biocatalyst for the transformation of bicyclic imines.  Together these residues may be 
interesting targets for future mutational studies designed to expand the substrate spectrum of 
AoIRED. 
In the ternary complex structure Asn171, equivalent to Asp and Tyr residues previously 
mooted to have roles in catalysis on the basis of homology to aldehyde dehydrogenase enzymes, 
is somewhat remote from the interaction between cofactor and amine in the active site. While we 
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cannot exclude a role in mechanism for the equivalent residue in other IREDs, certain homologs 
such as AoIRED clearly exist which have no requirement for a protic residue in this position for 
catalysis.  Mutation of Asn171 to Asp certainly did not increase AoIRED activity and, indeed, 
mutation to either Asp or Ala gave variants of higher Km and slightly altered stereoselectivity, 
possibly suggesting a partial role for Asn171 in early substrate recognition in AoIRED as it 
approaches the site of reduction.  
CONCLUSION 
AoIRED represents an interesting new addition to the library of IRED catalysts for applications 
in asymmetric synthesis. Previous studies suggest that these enzymes are applicable in either 
whole-cell reactions, in which substrate concentrations of up to 25 mM have been used,
15
  or as 
isolated enzymes, for which established methods of nicotinamide cofactor recycling can be 
applied.
11
   However, the studies of AoIRED again reveal that stereochemical control in these 
enzymes is complex and the prediction of selectivity is especially difficult, and has to be 
investigated on a case-by-case basis.  However, the description of a ternary complex of an IRED 
does provide new avenues for mutation directed at altering the substrate scope of this enzyme, 
and the mutations of Tyr179 and Asn241 suggests that this may be possible, with the increased 
activity towards certain substrates engendered by this mutation.  It is certain that further 
structural and mechanistic studies will be required to shed more light on mechanism and 
stereoselectivity and IREDs, and that the determinants of each may be different for subgroups of 
IREDs bearing different amino acids within their active sites. 
EXPERIMENTAL SECTION 
Chemicals 
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Commercially available chemicals and reagents were purchased from Sigma-Aldrich (Poole, 
Dorset, UK), Prozomix (Haltwhistle, Northumberland, UK), Alfa Aesar (Karlsruhe, Germany) 
and Acros Organics (Geel, Belgium) unless stated otherwise. HPLC solvents were obtained from 
Sigma-Aldrich (Poole, Dorset, UK) or ROMIL (Waterbeach, Cambridge, UK) and GC gases 
from BOC gases (Guildford, UK). Further general information is given in the Supporting 
Information (Section S1). 2-Methyl-1-pyrroline (1a), 2-methylpiperidine (4a), harmaline (13c) 
and 3,4-dihydroisoquinoline (7) were purchased from Sigma-Aldrich (Poole, Dorset, UK). 2-
Methylpyrrolidine (2a), 1-methyl-3,4-dihydroisoquinoline hydrochloride (9), 1-methyl-6,7-
dimethoxy-3,4-dihydroisoquinoline (11) and 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro-
isoquinoline hydrochloride (12) were sourced from Acros Organics (Geel, Belgium), 
2-phenylpyrrolidine (2b) was purchased from Apollo Scientific (Stockport, UK) and 1-methyl-
1,2,3,4 tetrahydroisoquinoline (10) was obtained from GlaxoSmithKline (Stevenage, UK). 
Compounds 3a-3d, 3g, 4a-4d, 4g, 5a & 5b, 6a & 6b, 13a & 13b and 14a and 14b were 
synthesised according to previously reported methods.11
,11,15
 Procedures for the preparation of 
3e, 3f, 4e, 4f, 15a-15d, 16a-16d, 17, 18, 19a, 19b, 20a and 20b and their characterization data 
are included in the Supporting Information (Section S4). 
Gene synthesis, cloning, expression and protein purification 
General information on strains and plasmids, and details of gene design and cloning protocols 
can be found in the Supporting Information (Section S2).  The codon-optimized gene sequence 
encoding AoIRED was synthesized by Biomatik (Cambridge, Ontario, Canada) and sub-cloned 
into pET28a-(+) vector using NdeI and XhoI restriction sites to form pET 28a-His-AoIRED 
plasmid (Figure S1). Site-directed mutants of AoIRED were generated using the Stratagene 
QuikChange site directed mutagenesis protocol, using primers as listed in the Supporting 
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Information (Section S2).  The presence of mutations in all constructs was verified by 
sequencing. Production of AoIRED was achieved in E. coli BL21 (DE3) which had been 
transformed with the recombinant AoIRED plasmid. Cultivation was performed in 500 mL 
lysogeny broth (LB) medium (1% tryptone, 0.5% yeast extract, 1% NaCl) with kanamycin (30 
μg  mL-1) added as the antibiotic marker. Cultures were initially incubated at 37°C with shaking 
at 250 r.p.m. At an optical density (OD600nm) of between 0.6 and 0.8, isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to a final concentration of 0.2 mM to induce the 
expression of AoIRED. Incubation was continued at 30°C and 250 r.p.m. for 18 h.  Cells were 
then harvested by centrifugation and resuspended in sodium phosphate buffer (100 mM, pH 7.5).  
Celles were disrupted using a Soniprep150 ultrasonicator (MSE, London, UK), employing 3 x 30 
s bursts with 30 s intervals at 4°C. Cell debris was removed by centrifugation, after which the 
resulting supernatant was loaded onto a 5 mL His-Trap HP column (GE healthcare). The protein 
was  eluted using a gradient of 0-300 mM imidazole in sodium phosphate buffer (100 mM, pH 
7.5) containing 300 mM NaCl. The purified enzyme was desalted using 30 kDa cut-off Centricon 
filters (15 mL), and washed twice with sodium phosphate buffer (100 mM, pH 7.5) to remove 
NaCl and imidazole. For protein for crystallisation, further purification by size exclusion 
chromatography (SEC) using a HiLoad 16/60 Superdex 75 PrepGrade (GE Healthcare) gel 
filtration column was performed. AoIRED was purified by SEC with Tris-HCl buffer (50 mM, 
pH 8.0) containing 500 mM NaCl. SEC trace (Figure S2) and SDS-PAGE analysis (Figure S3) 
can be found in the Supporting Information (Section S2).  The protein concentration was 
determined using Bradford assay against BSA as a concentration standard. 
Biotransformations 
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Whole cell biotransformation reactions typically contained E.coli BL21(DE3) resting cells 
containing expressed AoIRED (OD600nm of 50), 2 % (v/v) dimethylformamide, 5 mM imine 
substrate and 50 mM glucose in sodium phosphate buffer (100mM, pH 7.5).  Reactions were 
incubated at 30°C with shaking at 250 r.p.m. for 18 h.   
Biotransformations using isolated enzymes were performed with purified AoIRED employing 
glucose dehydrogenase (GDH)/NADPH as a cofactor recycling system. A typical 500 µL 
reaction mixture contained 20 mM D-glucose, 0.2 mg mL
-1
 GDH, 0.3 mM NADP
+
, 0.4 mg mL
-1
 
AoIRED 5 mM imine/iminium ion substrate and 2% (v/v) dimethyl formamide.  The reaction 
volume was made up to 500 µL with sodium phosphate buffer (100mM, pH 7.5). Reactions were 
incubated at 30°C with shaking at 250 r.p.m. shaking for 18 h, after which they were quenched 
by the addition of 30 µL of 10 M NaOH and extracted twice with 500 µL tert-butyl methyl ether. 
The organic fractions were combined and dried over anhydrous MgSO4 and analyzed on HPLC 
or GC using chiral columns. Details of columns and analytical methods, with chromatograms, 
can be found in the Supporting Information (Section S5).  
Enzyme Assays 
The imine-reducing activity of AoIRED was measured by monitoring the oxidation of NADPH 
using a Cary 300 UV-Vis spectrophotometer (Agilent, Santa Clara, CA, USA).  The 
consumption of NADPH was monitored at 340 (ε=6.22 mM−1 cm−1) or 370 nm (ε=2.216 
mM
−1 cm−1). The assay mixture in sodium phosphate buffer (100mM, pH 7.5) contained an 
imine substrate in concentrations of up to 30 mM, NADPH at concentration of 160 μM (340 nM) 
or 300 μM (370 nm), 1 % (v/v) DMSO and 10-50 μg of pure enzyme, in a total volume of 
1000 μL. Control reactions without substrate featuring the same reaction conditions were run to 
determine the background consumption of NADPH. The reaction was initiated upon the addition 
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of purified AoIRED to the mixture. A unit of AoIRED was equal to the amount of the pure 
enzyme required to consume 1 μmol NADPH/ NADP+ per min. Activity measurements were 
performed in triplicate and kinetic constants were determined through nonlinear regression based 
on Michaelis–Menten kinetics (QtiPlot software). 
Protein Crystallization 
Pure AoIRED was subjected to crystallization trials using a range of commercially-available 
screens in 96-well sitting-drop format, in which each drop consisted of 150 nL protein and 
150 nL of precipitant reservoir solution. The best hits for apo-AoIRED were found in conditions 
containing 0.2 M calcium acetate, 0.1 M Tris pH 9.0, 8% (w/v) PEG 550 monomethyl ether 
(MME) and 8% (w/v) PEG 20K with protein at a concentration of 20 mg mL
-1
. Larger crystals 
for diffraction analysis using optimized conditions were prepared using the hanging-drop method 
in 24-well plate Linbro dishes with 2 L drops consisting of 1:1 ratio of mother liquor to protein. 
The best crystals were obtained in conditions containing 0.2 M calcium acetate, 0.1 M Tris pH 
9.0, 8% (w/v) PEG 550 MME and 8% (w/v) PEG 20K with protein at a concentration of 20 mg 
mL
-1
. 
Co-crystallization of AoIRED with NADPH (10 mM) did not yield crystals under the same 
buffer conditions.  In order to obtain the NADPH complex of AoIRED, native crystals were 
transferred from the growth drop into a cryogenic solution which consisted of the mother liquor 
containing ethylene glycol [20% (v/v)] and NADPH (10 mM), and incubated for 5 min, after 
which they were immediately flash-cooled in liquid nitrogen.   
Crystals of AoIRED complexed with (R)-10 in the ‘closed’ conformation were obtained by 
subjecting pure AoIRED to crystallization trials using a range of commercially available screens 
in sitting-drop format with 1 mM NADPH and 1 mM rac-10 added into the mother liquor 1 h 
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prior to dispensing 150 nL protein and 150 nL of precipitant reservoir solution. The best hits for 
AoIRED complexed with (R)-10 were found in conditions containing 0.2 M lithium sulfate, 0.1 
M BisTris pH 6.5, 25% (w/v) PEG 3350, 1 mM NADPH and 1 mM rac-10 with protein at a 
concentration of 25 mg mL
-1
. Larger crystals for diffraction analysis using optimised conditions 
were prepared using sitting-drop format 48-well MRC MAXI crystallization plates with 1 μL 
drops consisting of 1:1 ratio of mother liquor to protein. The best crystals were obtained in 
conditions containing 0.25 M lithium sulfate, 0.1 M BisTris pH 6.5, 23% (w/v) PEG 3350, 1 mM 
NADPH and 1 mM rac-10. The AoIRED complex with (R)-10 in the ‘closed’ conformation was 
obtained by soaking the pre-complexed crystals with compound NADPH and rac-10 for 5 min 
prior to flash-cooling with liquid nitrogen without the addition of further cryoprotectants. 
All crystals were tested for diffraction in-house using a Rigaku Micromax-007HF fitted with 
Osmic multilayer optics and a Marresearch MAR345 imaging plate detector. Those crystals that 
diffracted to a resolution of equal to, or better than, 3 Å resolution were retained for dataset 
collection at the Diamond Light Source synchrotron. 
Data Collection, Structure Solution, Model Building and Refinement 
Complete datasets described in this report were collected at Diamond Light Source, Didcot, 
Oxfordshire, U.K.  The apo-AoIRED dataset was collected on beamline I03, the NADPH 
complex on beamline I04 and the ‘closed’ (R)-MTQ complex on beamline I02 utilizing 10% 
beam transmission and helical data collection.
32
 Data were processed and integrated using XDS
33
 
and scaled using SCALA
34
 included in the Xia2 processing system.
35
 Data collection statistics 
are given in the Supporting Information in Table S4.   The crystals of apo-AoIRED in the ‘open’ 
form were in space group C2221. The crystals of the ‘closed’ complexes were in group P212121. 
The structure of AoIRED was solved with MOLREP
36
 using a monomer model of the IRED 
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Q1EQE0, PDB code 3ZGY. The solution(s) in C2221 contained one molecule in the asymmetric 
unit; those in P212121 contained two monomers, representing one dimer.  The solvent content in 
the apo-, NADPH complex and ‘closed’ (R)-MTQ complex were 52.4%, 42.8% and 40.5% 
respectively.  The structures were built and refined using iterative cycles in Coot
37
 and 
REFMAC,
38
 the latter employing local NCS restraints.  For the NADPH complex of AoIRED, 
following building and refinement of the protein and water molecules, clear residual density was 
observed in the omit maps at one of the subunit dimer interfaces.  This was modelled and refined 
as NADPH. For the ternary complex, clear density was observed in the relevant binding pocket 
that could be modelled as (R)-MTQ.  The MTQ coordinate and refinement library file were 
prepared using PRODRG.
39
 All structures were finally validated using PROCHECK.
40
 
 
Refinement statistics for all structures are presented in Table S4.  The Ramachandran plot for the 
apo-AoIRED showed 97.5% of residues to be situated in the most favored regions, 2.1% in 
additional allowed and 0.4% residues in outlier regions.  For the NADPH complex, the 
corresponding values were 96.0%, 3.1% and 0.9% respectively and for the ‘closed’ (R)-MTQ 
complex, 97.3%, 2.3% and 0.4% respectively.  The coordinates and structure factors have been 
deposited in the Protein Databank with the accession codes 5a9r, 5a9s and 5fwn respectively.  
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Table of Contents Graphic and Synopsis 
The stereoselectivity of the Imine Reductase from Amycolatopsis orientalis (AoIRED) was 
observed to hinge upon small changes in substrate structure, and also, in one case, on the age and 
state of the biocatalyst.  Comprehensive activity screening, combined with structural studies, 
suggest that complex factors, including protein dynamics and substrate structure, combine to 
deliver different stereochemical outcomes for closely related imines. 
 
